The prevalence and impact of migraine headache in bipolar disorder: Results from the Canadian Community Health Survey

Headache

Volumn 46, Issue 6, 2006, Pages 973-982

  McIntyre, Roger S ^a,b   Konarski, Jakub Z ^c   Wilkins, Kathryn ^d   Bouffard, Beverley ^e   Soczynska, Joanna K ^f   Kennedy, Sidney H ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d HEALTH STATISTICS DIVISION   (Canada)

^e YORK UNIVERSITY   (Canada)

^f Mood Disorders Psychopharmacology Unit   (Canada)

Author keywords

Bipolar disorder; Comorbidity; Depression; Epidemiology; Gender; Migraine; Population; Statistics Canada

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BIPOLAR DISORDER; CANADA; COMORBIDITY; DAILY LIFE ACTIVITY; DEMOGRAPHY; DISEASE COURSE; FEMALE; HEADACHE; HEALTH CARE UTILIZATION; HEALTH SURVEY; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MANIA; MENTAL HEALTH SERVICE; MIGRAINE; ONSET AGE; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; SCREENING; SOCIAL ASPECT; WELLBEING;

ADOLESCENT; ADULT; BIPOLAR DISORDER; CANADA; COMORBIDITY; DEPRESSION; FEMALE; HEALTH SERVICES; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PREVALENCE; SEX DISTRIBUTION; SOCIAL CLASS;

EID: 33646936840     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2006.00469.x     Document Type: Article

References (40)

1. McIntyre RS, Konarski JZ. Bipolar disorder: A national health concern. CNS Spectr. 2004 9 suppl 12 6 15.
2. Kruit MC, van Buchem MA, Hofman PA, et al. Migraine as a risk factor for subclinical brain lesions. JAMA. 2004 291:427 434.
3. Low NC, Du Fort GG, Cervantes P. Prevalence, clinical correlates, and treatment of migraine in bipolar disorder. Headache. 2003 43:940 949.
4. McIntyre RS, Konarski JZ, Yatham LN. Comorbidity in bipolar disorder: A framework for rational treatment selection. Hum Psychopharmacol. 2004 19:369 386.
5. Hirschfeld RM, Calabrese JR, Weissman MM, et al. Screening for bipolar disorder in the community. J Clin Psychiatry. 2003 64:53 59.
6. Swartz KL, Pratt LA, Armenian HK, Lee LC, Eaton WW. Mental disorders and the incidence of migraine headaches in a community sample: Results from the baltimore epidemiologic catchment area follow-up study. Arch Gen Psychiatry. 2000 57:945 950.
7. Mahmood T, Romans S, Silverstone T. Prevalence of migraine in bipolar disorder. J Affect Disord. 1999 52:239 241.
8. Mahmood T, Silverstone T. Twin concordance for bipolar disorder and migraines. Am J Psychiatry. 2000 157:2057.
9. Fasmer OB, Oedegaard KJ. Clinical characteristics of patients with major affective disorders and comorbid migraine. World J Biol Psychiatry. 2001 2:149 155.
10. Fasmer OB. The prevalence of migraine in patients with bipolar and unipolar affective disorders. Cephalalgia. 2001 21:894 899.
11. Fasmer OB, Oedegaard KJ. Laterality of pain in migraine with comorbid unipolar depressive and bipolar ii disorders. Bipolar Disord. 2002 4:290 295.
12. Oedegaard KJ, Fasmer OB. Is migraine in unipolar depressed patients a bipolar spectrum trait¿ J Affect Disord. 2005 84:233 242.
13. Marchesi C, De Ferri A, Petrolini N, et al. Prevalence of migraine and muscle tension headache in depressive disorders. J Affect Disord. 1989 16:33 36.
14. Angst J, Gamma A, Benazzi F, et al. Atypical depressive syndromes in varying definitions. Eur Arch Psychiatry Clin Neurosci. 2005 256:44 54.
15. Feinstein AR, Walter SD, Horwitz RI. An analysis of Berkson's bias in case-control studies. J Chronic Dis. 1986 39:495 504.
16. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: Fourth Edtion Text revision (DSM-IV-TR), 4th ed. Washington:American Psychiatric Association 2000.
17. Kessler RC, Rubinow DR, Holmes C, Abelson JM, Zhao S. The epidemiology of DSM-III-R bipolar I disorder in a general population survey. Psychol Med. 1997 27:1079 1089.
18. Regier DA, Boyd JH, Burke JD Jr.., et al. One-month prevalence of mental disorders in the United States. Based on five epidemiologic catchment area sites. Arch Gen Psychiatry. 1988 45:977 986.
19. Mahmood T, Silverstone T, Connor R, Herbison P. Sumatriptan challenge in bipolar patients with and without migraine: A neuroendocrine study of 5-HT1D receptor function. Int Clin Psychopharmacol. 2002 17:33 36.
20. Yatham LN, Kennedy SH, O'Donovan C, et al. Canadian network for mood and anxiety treatments (CANMAT) guidelines for the management of patients with bipolar disorder: Consensus and controversies. Bipolar Disord. 2005 7 suppl 3 5 69.
21. Kennedy SH, Lam RW, Cohen NL, Ravindran AV. Clinical guidelines for the treatment of depressive disorders. IV. Medications and other biological treatments. Can J Psychiatry. 2001 46 suppl 1 38S 58S.
22. Dodick DW. Clinical practice. Chronic daily headache. N Engl J Med. 2006 354:158 165.
23. Garvey MJ, Tollefson GD, Schaffer CB. Migraine headaches and depression. Am J Psychiatry. 1984 141:986 988.
24. Gordon ML, Lipton RB, Brown SL, van Praag HM. The neuroendocrine challenge paradigm in headache research. Cephalalgia. 1995 15:292 296.
25. Beyer JL, Taylor WD, MacFall JR, et al. Cortical white matter microstructural abnormalities in bipolar disorder. Neuropsychopharmacology. 2005 30:2222 2229.
26. Konarski JZ, McIntyre RS, Grupp LA, Kennedy SH. Is the cerebellum relevant in the circuitry of neuropsychiatric disorders. J Psychiatry Neurosci. 2005 30:178 186.
27. Moja PL, Cusi C, Sterzi RR, Canepari C. Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headaches. Cochrane Database Syst Rev. 2005 20:CD002919.
28. Altshuler L, Suppes T, Black D, et al. Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up. Am J Psychiatry. 2003 160:1252 1262.
29. Yonkers KA, Wisner KL, Stowe Z, et al. Management of bipolar disorder during pregnancy and the postpartum period. Am J Psychiatry. 2004 161:608 620.
30. Altshuler LL. The use of SSRIs in depressive disorders specific to women. J Clin Psychiatry. 2002 63 suppl 7 3 8.
31. McIntyre RS, Konarski JZ, Grigoriadis S, et al. Hormone replacement therapy and antidepressant prescription patterns: A reciprocal relationship. CMAJ. 2005 172:57 59.
32. Rasgon N, Bauer M, Grof P, Gyulai L, et al. Sex-specific self-reported mood changes by patients with bipolar disorder. J Psychiatr Res. 2005 39:77 83.
33. Frye MA, Altshuler LL, McElroy SL, et al. Gender differences in prevalence, risk, and clinical correlates of alcoholism comorbidity in bipolar disorder. Am J Psychiatry. 2003 160:883 889.
34. Kennedy N, Boydell J, Kalidindi S, et al. Gender differences in incidence and age at onset of mania and bipolar disorder over a 35-year period in Camberwell, England. Am J Psychiatry. 2005 162:257 262.
35. Geller B, Fox LW, Clark KA. Rate and predictors of prepubertal bipolarity during follow-up of 6- to 12-year-old depressed children. J Am Acad Child Adolesc Psychiatry. 1994 33:461 468.
36. McIntyre RS, Konarski JZ, Misener VL, Kennedy SH. Bipolar disorder and diabetes mellitus: Epidemiology, etiology, and treatment implications. Ann Clin Psychiatry. 2005 17:83 93.
37. Beyer J, Kuchibhatla M, Gersing K, Krishnan KR. Medical comorbidity in a bipolar outpatient clinical population. Neuropsychopharmacology. 2005 30:401 404.
38. Edmeads J, Findlay H, Tugwell P, Pryse-Phillips W, Nelson RF, Murray TJ. Impact of migraine and tension-type headache on life-style, consulting behaviour, and medication use: A Canadian population survey. Can J Neurol Sci. 1993 20:131 137.
39. Lipton RB, Stewart WF, Simon D. Medical consultation for migraine: Results from the American migraine study. Headache. 1998 38:87 96.
40. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994 51:8 19.